治疗镰状细胞贫血：一个新时代来临。 - Suppr

Suppr

超能文献

Treating sickle cell anemia: A new era dawns.

作者信息

Steinberg Martin H

机构信息

Department of Medicine, Division of Hematology/Oncology, Boston University School of Medicine, Boston, Massachusetts.

出版信息

Am J Hematol. 2020 Apr;95(4):338-342. doi: 10.1002/ajh.25724. Epub 2020 Jan 21.

DOI:10.1002/ajh.25724

PMID:31925819

Abstract

摘要

相似文献

Treating sickle cell anemia: A new era dawns.

Am J Hematol. 2020 Apr;95(4):338-342. doi: 10.1002/ajh.25724. Epub 2020 Jan 21.

Two drugs for sickle cell disease.

Med Lett Drugs Ther. 2020 Apr 6;62(1595):51-52.

Sickle Cell Disease: A Review.

JAMA. 2022 Jul 5;328(1):57-68. doi: 10.1001/jama.2022.10233.

Time to rethink haemoglobin threshold guidelines in sickle cell disease.

Br J Haematol. 2021 Nov;195(4):518-522. doi: 10.1111/bjh.17578. Epub 2021 Jun 15.

Sickle cell anemia and COVID-19: Use of voxelotor to avoid transfusion.

Transfusion. 2020 Dec;60(12):3066-3067. doi: 10.1111/trf.16068. Epub 2020 Sep 24.

Sickle cell pain & hydroxyurea.

Am J Nurs. 2000 Nov;100(11):34-8; quiz 38-9.

Voxelotor (GBT440), a first-in-class hemoglobin oxygen-affinity modulator, has promising and reassuring preclinical and clinical data.

Am J Hematol. 2018 Mar;93(3):326-329. doi: 10.1002/ajh.25042.

How do we monitor hemoglobin S in patients who undergo red blood cell exchange and take voxelotor?

Transfusion. 2021 Jun;61(6):1680-1683. doi: 10.1111/trf.16405. Epub 2021 Apr 20.

Voxelotor for the Treatment of Sickle Cell Disease.

Nurs Womens Health. 2020 Jun;24(3):233-237. doi: 10.1016/j.nwh.2020.03.003. Epub 2020 May 6.

Globin gene studies create a puzzle.

Science. 1984 Feb 3;223(4635):470-1. doi: 10.1126/science.6197757.

引用本文的文献

Sickle cell disease: understanding pathophysiology, clinical features and advances in gene therapy approaches.

Front Pharmacol. 2025 Aug 22;16:1630994. doi: 10.3389/fphar.2025.1630994. eCollection 2025.

Genetic reversal of the globin switch concurrently modulates both fetal and sickle hemoglobin and reduces red cell sickling.

Nat Commun. 2023 Sep 20;14(1):5850. doi: 10.1038/s41467-023-40923-5.

World Sickle Cell Day 2022: Progress & prospects.

Indian J Med Res. 2022 Jul;156(1):10-13. doi: 10.4103/ijmr.ijmr_1049_22.

L-glutamine for sickle cell disease: more than reducing redox.

Ann Hematol. 2022 Aug;101(8):1645-1654. doi: 10.1007/s00277-022-04867-y. Epub 2022 May 14.

Medical and Non-medical Costs of Sickle Cell Disease and Treatments from a US Perspective: A Systematic Review and Landscape Analysis.

Pharmacoecon Open. 2022 Jul;6(4):469-481. doi: 10.1007/s41669-022-00330-w. Epub 2022 Apr 26.

Crizanlizumab for the Prevention of Vaso-Occlusive Pain Crises in Sickle Cell Disease.

J Pharm Technol. 2021 Aug;37(4):209-215. doi: 10.1177/87551225211008460. Epub 2021 Apr 19.

Making hydroxyurea affordable for sickle cell disease in Tanzania is essential (HASTE): How to meet major health needs at a reasonable cost.

Am J Hematol. 2021 Jan;96(1):E2-E5. doi: 10.1002/ajh.26007. Epub 2020 Oct 6.

Changing the Clinical Paradigm of Hydroxyurea Treatment for Sickle Cell Anemia Through Precision Medicine.

Clin Pharmacol Ther. 2021 Jan;109(1):73-81. doi: 10.1002/cpt.2028. Epub 2020 Oct 8.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Treating sickle cell anemia: A new era dawns.

Am J Hematol. 2020 Apr;95(4):338-342. doi: 10.1002/ajh.25724. Epub 2020 Jan 21.

Two drugs for sickle cell disease.

Med Lett Drugs Ther. 2020 Apr 6;62(1595):51-52.

Sickle Cell Disease: A Review.

JAMA. 2022 Jul 5;328(1):57-68. doi: 10.1001/jama.2022.10233.

Time to rethink haemoglobin threshold guidelines in sickle cell disease.

Br J Haematol. 2021 Nov;195(4):518-522. doi: 10.1111/bjh.17578. Epub 2021 Jun 15.

Sickle cell anemia and COVID-19: Use of voxelotor to avoid transfusion.

Transfusion. 2020 Dec;60(12):3066-3067. doi: 10.1111/trf.16068. Epub 2020 Sep 24.

Sickle cell pain & hydroxyurea.

Am J Nurs. 2000 Nov;100(11):34-8; quiz 38-9.

Voxelotor (GBT440), a first-in-class hemoglobin oxygen-affinity modulator, has promising and reassuring preclinical and clinical data.

Am J Hematol. 2018 Mar;93(3):326-329. doi: 10.1002/ajh.25042.

How do we monitor hemoglobin S in patients who undergo red blood cell exchange and take voxelotor?

Transfusion. 2021 Jun;61(6):1680-1683. doi: 10.1111/trf.16405. Epub 2021 Apr 20.

Voxelotor for the Treatment of Sickle Cell Disease.

Nurs Womens Health. 2020 Jun;24(3):233-237. doi: 10.1016/j.nwh.2020.03.003. Epub 2020 May 6.

Globin gene studies create a puzzle.

Science. 1984 Feb 3;223(4635):470-1. doi: 10.1126/science.6197757.

引用本文的文献

Sickle cell disease: understanding pathophysiology, clinical features and advances in gene therapy approaches.

Front Pharmacol. 2025 Aug 22;16:1630994. doi: 10.3389/fphar.2025.1630994. eCollection 2025.

Genetic reversal of the globin switch concurrently modulates both fetal and sickle hemoglobin and reduces red cell sickling.

Nat Commun. 2023 Sep 20;14(1):5850. doi: 10.1038/s41467-023-40923-5.

World Sickle Cell Day 2022: Progress & prospects.

Indian J Med Res. 2022 Jul;156(1):10-13. doi: 10.4103/ijmr.ijmr_1049_22.

L-glutamine for sickle cell disease: more than reducing redox.

Ann Hematol. 2022 Aug;101(8):1645-1654. doi: 10.1007/s00277-022-04867-y. Epub 2022 May 14.

Medical and Non-medical Costs of Sickle Cell Disease and Treatments from a US Perspective: A Systematic Review and Landscape Analysis.

Pharmacoecon Open. 2022 Jul;6(4):469-481. doi: 10.1007/s41669-022-00330-w. Epub 2022 Apr 26.

Crizanlizumab for the Prevention of Vaso-Occlusive Pain Crises in Sickle Cell Disease.

J Pharm Technol. 2021 Aug;37(4):209-215. doi: 10.1177/87551225211008460. Epub 2021 Apr 19.

Making hydroxyurea affordable for sickle cell disease in Tanzania is essential (HASTE): How to meet major health needs at a reasonable cost.

Am J Hematol. 2021 Jan;96(1):E2-E5. doi: 10.1002/ajh.26007. Epub 2020 Oct 6.

Changing the Clinical Paradigm of Hydroxyurea Treatment for Sickle Cell Anemia Through Precision Medicine.

Clin Pharmacol Ther. 2021 Jan;109(1):73-81. doi: 10.1002/cpt.2028. Epub 2020 Oct 8.